Pura Vida Investments, LLC Immuno Gen, Inc. Transaction History

Pura Vida Investments, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$4.55 - $6.31 $227,500 - $315,500	50,000 New	50,000 $248,000
Q1 2022 May 16, 2022	SELL	$4.26 - $7.48 $1.06 Million - $1.86 Million	-249,283 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$4.75 - $7.5 $445,383 - $703,237	-93,765 Reduced 27.33%	249,283 $1.85 Million
Q3 2021 Nov 15, 2021	SELL	$5.02 - $6.59 $1.74 Million - $2.28 Million	-346,001 Reduced 50.21%	343,048 $1.95 Million
Q2 2021 Aug 16, 2021	SELL	$5.79 - $8.6 $666,677 - $990,229	-115,143 Reduced 14.32%	689,049 $4.54 Million

Q1 2021 May 12, 2021	BUY	$6.5 - $10.53 $1.23 Million - $1.99 Million	188,906 Added 30.7%	804,192 $6.51 Million
Q4 2020 Feb 16, 2021	BUY	$3.7 - $7.66 $2.28 Million - $4.71 Million	615,286 New	615,286 $3.97 Million

1.41M

Ticker IMGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 220,712,992
Description
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...

Get notified when there are updates to the investment portfolio of Pura Vida Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Pura Vida Investments, LLC with notifications on news.